Found: 15
Select item for more details and to access through your institution.
Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 284, doi. 10.1111/bjh.18853
- By:
- Publication type:
- Article
Hairy cell leukemia with isolated bone lesions.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5210, doi. 10.3390/cancers13205210
- By:
- Publication type:
- Article
CPX-351 versus 7+3 dans la leucémie aiguë myéloïde du sujet âgé : avantage en survie globale conservée à cinq ans.
- Published in:
- Hematologie, 2021, v. 27, n. 5, p. 215, doi. 10.1684/hma.2021.1690
- By:
- Publication type:
- Article
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3554, doi. 10.3390/jcm9113554
- By:
- Publication type:
- Article
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2885, doi. 10.3390/cancers12102885
- By:
- Publication type:
- Article
L'essai ICARIA-MM : un nouveau standard de traitement pour le myélome multiple en rechute ou réfractaire au lénalidomide et aux inhibiteurs du protéasome ? [1].
- Published in:
- Hematologie, 2020, v. 26, n. 1, p. 7, doi. 10.1684/hma.2020.1510
- By:
- Publication type:
- Article
Un CAR peut en cacher un autre : cellules CAR-T anti-CD22 dans la leucémie aiguë lymphoblastique B en rechute ou réfractaire.
- Published in:
- Hematologie, 2020, v. 26, n. 1, p. 9, doi. 10.1684/hma.2020.1512
- By:
- Publication type:
- Article
Pomalidomide 3rd line versus 4th line for in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.427
- By:
- Publication type:
- Article
Weekly 20/56mg/m2 Carfilzomib, Lenalidomide and Dexamethasone until progression in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.426
- By:
- Publication type:
- Article
Response to pneumococcal vaccination in multiple myeloma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3822, doi. 10.1002/cam4.2253
- By:
- Publication type:
- Article
Carfilzomib weekly 20/56 mg/m<sup>2</sup>, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E17, doi. 10.1002/ajh.25327
- By:
- Publication type:
- Article
Particularités immunologiques de la thrombopénie induite à l'héparine.
- Published in:
- Hematologie, 2017, v. 23, n. 3, p. 179, doi. 10.1684/hma.2017.1267
- By:
- Publication type:
- Article
Classification génomique pronostique dans la leucémie aiguë myéloïde .
- Published in:
- Hematologie, 2016, v. 22, n. 4, p. 245, doi. 10.1684/hma.2016.1158
- By:
- Publication type:
- Article
Beacopp versus ABVD dans le lymphome de Hodgkin de stade avancé : une étude de phase III de l’EORTC .
- Published in:
- Hematologie, 2016, v. 22, n. 4, p. 246, doi. 10.1684/hma.2016.1159
- By:
- Publication type:
- Article